PF-Atlas › Clinical Trials › NCT07325357
Effect of Pirfenidone on TA Fibrosis
Pirfenidone Capsules · Phase 4
Registry ID
NCT07325357
Phase
Phase 4
Status
Not yet recruiting
Drug / intervention
Pirfenidone Capsules
Sponsor
Shanghai Zhongshan Hospital
Start
2025-12-20
About this trial
Pirfenidone Capsules is evaluated in NCT07325357, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Shanghai Zhongshan Hospital. Current status: Not yet recruiting.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT07325357 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.